GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.7858 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1027 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, MPO, PTGS2, RORC, SRC, TYR |
10.7077 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, IDO1, MPO, PIM1, PTGS2, TBXAS1, TYR, XDH |
9.49987 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IDO1, IGF1R, MPO, POLB, PTGS2, RORC, SRC, TYR |
8.80971 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
8.75814 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MPO, POLB, PTGS2, RORC, SRC, TYR |
8.03243 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
7.97381 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.46618 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PTGS2, TBXAS1 |
6.79361 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.47535 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MPO, PTGS2, TBXAS1, TYR, XDH |
6.40636 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1B1, ESR1, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, POLA1, POLB, PTGS2, SRC, TNKS, TNKS2, XDH |
6.40463 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.38455 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MPO, POLB, PTGS2, RORC, SRC, TYR |
6.12074 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTGS2, RORC, SRC, TYR |
6.04404 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3 |
5.12348 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PTGS2, SRC |
4.78838 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MPO, PIM1, POLB, PTGS2, RORC, SRC, TNKS2, TYR |
4.72475 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, POLB, SRC, TYR |
4.68125 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F2, F3, FLT3, HCAR2, HTR6, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.66805 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F2, F3, FLT3, HCAR2, HTR6, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.64776 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, F2, HCAR2, KDR, PTGS2, SRC, TNKS, TNKS2 |
4.61109 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.56409 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IDO1, IGF1R, KDR, MET, MPO, PIM1, PTGS2, PTPN1, SRC, XDH |
4.55977 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.46891 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FLT3, GBA2, HSD11B1, HSD17B2, KDR, PIM1, POLB, PTGS2, RORC, SRC, TYR |
4.41193 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA3, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KDR, POLB, PTGS2, SRC |
4.31586 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.18354 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, FLT3, IDO1, IGF1R, KDR, PIM1, PTGS2, SRC, XDH |
4.10413 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IDO1, IGF1R, KDR, MET, MPO, PIM1, PTGS2, PTPN1, SRC, XDH |
4.09172 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, MET, PIM1, POLA1, SRC, TYR |
4.08242 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3 |
4.07159 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IDO1, IGF1R, KDR, MPO, PIM1, PTGS2, PTPN1, SRC, XDH |
3.99503 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, PTGS2, SRC |
3.88838 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
3.86271 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HCAR2, HTR6, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.86271 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, PTGS2, SRC |
3.6618 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.59473 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IDO1, IGF1R, KDR, MET, MPO, PIM1, PTGS2, PTPN1, SRC |
3.57456 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CA3, CYP1A1, CYP1B1, KDR, POLB, SRC |
3.57456 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, F2, HCAR2, PTGS2, TNKS, TNKS2 |
3.57151 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.57151 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.57151 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, ESR1, F2, F3, FLT3, IGF1R, KDR, PIM1, PTGS2 |
3.52304 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.52304 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.46883 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MPO |
3.46883 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.43086 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MPO, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TYR |
3.31 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, RORC, SRC |
3.30211 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IDO1, IGF1R, KDR, MET, MPO, PIM1, PTGS2, PTPN1, SRC |
3.23013 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HTR6, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.19443 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MET, PTGS2, TBXAS1 |
3.17702 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, F2, F3, FLT3, HTR6, KDR, MET, PTGS2, PTPN1, SRC, XDH |
3.12977 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLB, PTGS2, PTPN1, SRC, TNKS, XDH |
3.12977 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
3.09588 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC |
3.06832 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.05643 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.05643 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IDO1, IGF1R, KDR, MPO, PIM1, PTGS2, PTPN1, SRC |
3.05643 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
3.05236 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.03211 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, RORC, SRC |
2.99498 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC |
2.88851 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, F2, F3, FLT3, HTR6, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.88174 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLB, PTGS2, PTPN1, SRC, TNKS, XDH |
2.87579 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTGS2, SRC |
2.78118 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, PTGS2, RORC, SRC |
2.78118 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F2, F3, FABP4, HSD11B2, HSD17B2, IDO1, IGF1R, MET, MPO, PIM1, PTGS2, RORC, SRC, TNKS2, TYR |
2.76211 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.70513 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.68747 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.67366 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, MPO, PTGS2, SRC, TYR |
2.63577 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, F2, IDO1, MPO, PTGS2, SRC |
2.63577 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.63398 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTGS2, SRC |
2.63398 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
2.63398 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
2.62074 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F2, F3, FABP4, FLT3, HTR6, IDO1, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.5726 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.54675 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.54675 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F2, F3, FLT3, HTR6, IGF1R, KDR, MET, PTGS2, PTPN1, SRC, XDH |
2.52634 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CA3, CYP1B1, MPO, PTGS2, SRC |
2.52584 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.50215 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, F2, IDO1, MPO, PTGS2, SRC |
2.49993 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.49613 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.49613 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, RORC, SRC |
2.49613 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC |
2.47871 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
2.47871 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, PTGS2, RORC, SRC |
2.47871 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, POLA1, POLB, PTGS2, PTPN1, RORC, SRC |
2.45912 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MPO |
2.44375 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.43405 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, F2, FABP3, FLT3, HCAR2, PTGS2, RORC, SRC |
2.38959 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PTGS2, SRC |
2.38487 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, PTGS2, TBXAS1 |
2.37169 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.37169 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.35782 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.34969 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, BCL2, CA12, CA2, CA7, ESR1, F2, FABP3, FABP4, FLT3, MET, POLA1, POLB, SRC |
2.34969 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.34412 |
[BP] GO:0040012 |
regulation of locomotion
|
BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, PTGS2, SRC |
2.33038 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.32805 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.32805 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.32805 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.30376 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
F2, F3, FABP4, IDO1, KDR, MET, PTGS2 |
2.27378 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.27325 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KDR, PTGS2, SRC |
2.25272 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.2206 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.2206 |
[BP] GO:0032094 |
None
|
CYP1A1, HSD11B2, MPO |
2.2206 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.2206 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.20149 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.16336 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PTGS2, TBXAS1 |
2.14331 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, PTGS2, SRC |
2.14331 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, HSD11B2, MPO, PTGS2, SRC, TYR |
2.13952 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO |
2.12717 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, MPO, PIM1, PTGS2, TBXAS1, TYR |
2.12717 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.12717 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.12717 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.12717 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.11956 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.10184 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.10184 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.10184 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.10184 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, F2, KDR, SRC |
2.10184 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, MPO, PIM1, PTGS2, TBXAS1, TYR |
2.07892 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, IDO1, MPO, SRC, XDH |
2.07018 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.01813 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F2, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1, TBXAS1 |
2.07892 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, F2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, KDR, MPO, PIM1, POLA1, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.02794 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.79075 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2, TBXAS1 |
1.71054 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F2, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR6, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TYR |
1.4155 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2026 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, PIM1, PTPN1, RORC, TBXAS1, TNKS, TYR, XDH |
13.148 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
13.148 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0818 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
12.5834 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HSD17B1, IDO1, IGF1R, KDR, MET, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
10.136 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
8.80971 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MPO, PTGS2, TBXAS1, TYR, XDH |
7.71452 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, IDO1, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TYR, XDH |
6.99277 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, IDO1, MPO, PIM1, POLA1, POLB, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TYR, XDH |
6.61734 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS2, SRC, TBXAS1 |
6.42982 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, IDO1, MPO, POLA1, PTGS2, SRC, TBXAS1, XDH |
6.38556 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS2, SRC, TBXAS1 |
6.23808 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, PTPN1, RORC, TNKS |
6.23808 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
5.03098 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.98765 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.54081 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
3.86271 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
3.6618 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
3.6618 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.58364 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1, TYR |
3.57151 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.52304 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
3.35355 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.34652 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.34652 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, RORC |
3.34112 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.30052 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.28586 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD11B2, HSD17B1, RORC |
3.28586 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.19443 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.16556 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CDK6, CHRM1, CHRM2, CHRM4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, RORC |
3.14331 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.86326 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR6 |
2.7995 |
[MF] GO:0004872 |
receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, RORC |
2.76795 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.67366 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.67366 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.60465 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.5726 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.37169 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CHRM1, CHRM2, CHRM4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, RORC |
2.34969 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.34969 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.32477 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM4, HTR6 |
2.27325 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.14392 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.10184 |